Using a combination of autofluorescence imaging (AFI)-guided biopsies and molecular markers, they concluded that aneuploidy, p53 immunohistochemistry, and cyclin A were the biomarkers most strongly associated with high-grade dysplasia (HGD) and early cancer (EC). The gene discussed is CCNA2; the disease is cancer.